LPAR5 and Stroke: LPA5 is considered to be a driving factor for acute and chronic ischemic injuries in the mouse transient middle cerebral artery occlusion (tMCAO) stroke model, and the LPA5 antagonist TCLPA5 has been shown to confer acute and long-term protection in this injury model [22,23].